• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,699.28 -99.76
(-0.19%)
Dow Jones
7,668.45 9.69
(0.13%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,654.81 -161.33
(-1.49%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3529756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
38.94
3226.59
EPS(TTM)
Face Value()
Div & Yield %
7.4
2
1.86
 

Contil India standalone net profit rises 2.27% in the March 2026 quarter
May 29,2026
Net profit of Contil India rose 2.27% to Rs 0.45 crore in the quarter ended March 2026 as against Rs 0.44 crore during the previous quarter ended March 2025. Sales rose 0.70% to Rs 7.16 crore in the quarter ended March 2026 as against Rs 7.11 crore during the previous quarter ended March 2025.

For the full year,net profit declined 9.49% to Rs 2.29 crore in the year ended March 2026 as against Rs 2.53 crore during the previous year ended March 2025. Sales declined 2.89% to Rs 31.63 crore in the year ended March 2026 as against Rs 32.57 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7.167.11 1 31.6332.57 -3
OPM %1.407.03 -4.208.23 -
PBDT0.590.55 7 3.113.39 -8
PBT0.550.52 6 3.033.34 -9
NP0.450.44 2 2.292.53 -9